BEOVU sol inj 6 mg/0.05ml ser préremp 0.165 ml
7680672440019
CH-67244
S01LA06
11.99.0.
Reimbursement limitations:
BEOVU.01
Pour le traitement de la dégénérescence maculaire liée à l’âge exsudative (humide) (DMLA).
BEOVU ne …
1 / 3
google
Details
- Product number
- 6724401
- CPT
- -
- Packaging group
- 1
- Unit
- Fertigspritze(n)
- Composition
- brolucizumabum 120 mg, saccharum, natrii citras anhydricus, polysorbatum 80, natrii hydroxidum, aqua ad iniectabile, ad solutionem pro 1 ml.
Articles (1)
Beovu 120mg/1ml, Injektionslösung in Fertigspritze
Injektionslösung in Fertigspritze
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
120.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 726.50
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/06/2020
Authorization holder
Novartis Pharma Schweiz AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 67244
- Drug name
- Beovu, Injektionslösung in Fertigspritze
- Galenic form
- LSINJ
- ATC Code
- S01LA06
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 16/01/2020
- Authorization expiration date
- 31/12/9999
- IT number
- 11.99.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- BEOVU sol inj 6 mg/0.05ml ser préremp 0.165 ml
- Description (DE)
- BEOVU Inj Lös 6 mg/0.05ml Fertigspr 0.165 ml
- Market launch
- 16/01/2020
- Narcotic (BTM)
- No